Liver biopsy is the gold standard for identifying the nature, activity and fibrosis stage of liver diseases. Thanks to its distinctive design, the Menghini liver biopsy needle has secured a core position in percutaneous liver biopsy after decades of clinical application. Its use has expanded from simple diagnosis to treatment evaluation and prognosis assessment, and its design incorporates comprehensive safety considerations.

Core Application Scenarios: From Diffuse Lesions to Focal Space-Occupying Lesions

1. Evaluation of Chronic Liver Diseases

• Viral hepatitis: Stages liver fibrosis (e.g., Metavir scoring) and grades inflammatory activity, to guide antiviral treatment and assess therapeutic outcomes.
• Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH): Confirms NASH and differentiates simple steatosis from steatohepatitis. It is an essential tool for current pharmaceutical clinical trials and efficacy evaluation.
• Autoimmune liver diseases: Applied to autoimmune hepatitis and primary biliary cholangitis for definitive diagnosis, severity assessment and guidance on immunosuppressive therapy.
• Unexplained abnormal liver function: Biopsy serves as the definitive diagnostic method when serological and imaging examinations fail to identify the cause.

2. Diagnosis of Focal Liver Lesions

For liver nodules or masses with atypical imaging manifestations, Menghini needle biopsy under ultrasound or CT guidance is critical to distinguish benign lesions from malignancies, including hepatocellular carcinoma, cholangiocarcinoma, metastatic carcinoma, hemangioma and focal nodular hyperplasia.

3. Surveillance of Liver Grafts

After liver transplantation, the needle is used to detect rejection, recurrence of primary diseases and drug-induced liver injury.

Safety Design Principles of the Menghini Needle

Its high safety profile is achieved through a series of well-conceived design details:

• Rapid sampling to reduce movement-related injury: The one-second biopsy technique drastically shortens the dwell time of the needle tip inside the liver, lowering the risk of liver parenchyma laceration caused by patient movement due to breathing or pain.
• Negative pressure aspiration to mitigate bleeding risks: Instant negative pressure generated upon needle penetration theoretically pulls or collapses small blood vessels ahead of the tip. Tissue is rapidly aspirated into the lumen, minimizing vascular transection along the needle tract and reducing the incidence of postoperative bleeding, the most severe complication.
• Blunt stylet for tissue and sample protection: Most Menghini needles are paired with a blunt stylet. The stylet advances ahead of the cutting tip during puncture to displace blood vessels and other structures, further preserving sample integrity and enhancing safety.
• Seamless integration with modern imaging technology: Contemporary Menghini biopsy is predominantly performed under real-time ultrasound guidance. Ultrasound clearly visualizes the needle path to avoid major blood vessels, the gallbladder and other vital structures. Such visualized puncture minimizes the risks associated with blind biopsy.

Manners Technology's Commitment to Clinical Safety

As a professional manufacturer, Manners Technology ensures consistent clinical performance of every needle via stringent process control. 5-axis laser cutting delivers uniformly sharp needle tips for smooth penetration; electropolishing creates ultra-smooth surfaces to reduce tissue friction; rigorous dimensional and patency tests guarantee efficient negative pressure transmission.

All products comply with the ISO 13485 medical device quality management system. Risk management and quality assurance are implemented throughout design and production, providing a reliable hardware foundation for clinical procedures.

Conclusion

The Menghini liver biopsy needle combines efficient sampling performance with sophisticated safety design. Supported by modern imaging technology, it has become a safe and effective diagnostic tool for hepatologists. The precision manufacturing by Manners Technology ensures stable and reliable performance of the device in clinical use, laying a solid foundation for the practice of precision hepatology.